EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recommendations for the re-analysis of existing genomic data from patients with epilepsy

Alan J Robertson, Natalie B Tan, Pei Dai, Carmen Bennett, Clair Sullivan, Zornitza Stark, Lata Vadlamudi, Nicola Waddell

Genetics in Medicine Open · 2026 · 4 · 104494

DOI: 10.1016/j.gimo.2026.104494 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genetics in Medicine Open, 2026. Verfasst von Alan J Robertson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Queensland Health, Digital Health CRC, University of Queensland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genomic testing is being recognized as an integral part of the management of individuals with epilepsy. However, despite the increasing utility of genomic testing in epilepsy, a substantial proportion of patients who are suspected to have a monogenic cause do not receive a molecular diagnosis. Reanalyzing existing genomic data increases the molecular diagnostic yield over time. As our understanding of the molecular components of epilepsy is changing faster than that of many other conditions, the re-analysis of existing genomic data from patients with epilepsy holds considerable potential for improving diagnostic outcomes. Given the complexity involved in the re-analysis of existing genomic data, neurologists may be unsure how to best incorporate this into their clinical practice following an initial uninformative genomic result. Here, we describe recommendations specifically designed to guide the re-analysis of existing genomic data for individuals with epilepsy with an unknown etiology. We synthesize current evidence and apply these findings to the specifics of genetic epilepsy to determine the best approaches to integrate re-analysis into clinical practice in a sustainable manner that maximizes benefits to patients.

Schlagwörter

Stichwörter der Autor:innen

Clinical recommendationsEpilepsyGenetic testingRe-analysis intervalsRe-analysis recommendations

Autor:innen und Institutionen

  • Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
  • Medical Genomics Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Queensland Digital Health Centre, University of Queensland, Brisbane, QLD, Australia.
  • Sullivan Nicolaides Pathology, Brisbane, Australia.
  • Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Department of Paediatrics, Melbourne Medical School, The University of Melbourne, Parkville, VIC, Australia.

Förderung

  • Queensland Health
  • Digital Health CRC
  • University of Queensland

Zitieren

APA

Robertson, A. J., Tan, N. B., Dai, P., Bennett, C., Sullivan, C., Stark, Z., Vadlamudi, L., & Waddell, N. (2026). Recommendations for the re-analysis of existing genomic data from patients with epilepsy. Genetics in Medicine Open, 4, 104494. https://doi.org/10.1016/j.gimo.2026.104494

Vancouver

Robertson AJ, Tan NB, Dai P, Bennett C, Sullivan C, Stark Z, et al. Recommendations for the re-analysis of existing genomic data from patients with epilepsy. Genetics in Medicine Open. 2026;4:104494. doi:10.1016/j.gimo.2026.104494

BibTeX
@article{Robertson2026,
  author = {Robertson, Alan J and Tan, Natalie B and Dai, Pei and Bennett, Carmen and Sullivan, Clair and Stark, Zornitza and Vadlamudi, Lata and Waddell, Nicola},
  title = {Recommendations for the re-analysis of existing genomic data from patients with epilepsy},
  journal = {Genetics in Medicine Open},
  year = {2026},
  volume = {4},
  pages = {104494},
  doi = {10.1016/j.gimo.2026.104494}
}
Kostenlos starten →